glp 1 agonist in heart failure Effects of Glucagon-Like Peptide Receptor Initiation Patients With With Reduced Ejection Fraction and Implantable Cardiac Devices Frontiers | Glucagon-like peptide-1 receptor
Description
doi: 10.1517/13543780902766802 119 ZhangYLiYZhaoJWangCDengBZhangQet al
GLP-1RA use and thyroid cancer risk
Exercise and type 2 diabetes: The American College of Sports Medicine and the American Diabetes Association: Joint position statement
More research is still needed to understand the role this medication could play as a potential preventive therapy for high-risk patients
Engl., vol
One in eight Americans are taking or have taken a glucagon-like peptide-1 receptor agonist (GLP-1)
